Prosight Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Prosight Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$2.31M	Buy
2019 Q2	$6.69M	Buy
2019 Q1	$6.19M	Buy
2018 Q4	$1.08M	Buy
2018 Q2	–	Sell
2018 Q1	$2.43M	Buy
2017 Q4	$2.72M	Buy